Progress in Lipid Research

Progress in Lipid Research is published by Elsevier Ltd and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Fatty Acid Research and Health, Lipid metabolism and biosynthesis and Peroxisome Proliferator-Activated Receptors, together about 28.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Publishing Invited ReviewsThe importance of lipids as one of the fundamental classes of biological compounds is well established. The application of our of the biochemistry, chemistry and physiology of lipids to biotechnology, the fats and oils industry and medicine have continued to expand apace. In addition new dimensions such as lipid biophysics, especially with relevance to membranes and lipoproteins, and basic liposome research and applications have been added. To cope with all these advances in knowledge a journal is needed to review recent progress in particular fields and to set current research against its historical background. Progress in Lipid Research fulfils this role.Each volume contains up-to-date surveys of special aspects of lipid research. The invited reviews are comprehensive enough to provide sufficient overview but concentrate on reporting and critically appraising the most recent data. Subjects are chosen for their timeliness or because major developments have taken place in the last few years. They include methodological reviews as well as chemical, biochemical and medical articles. All lipid compounds and derivatives are covered, ranging from fatty acids and other simple molecules, through steroids, terpenoids and phospho- or glycolipids to complex structures such as lipoproteins and biological membranes. We hope that those whose main interest is in lipid biophysics and liposome research will join as new readers, benefiting from the journal's classical aspects of lipid metabolism, lipids in signal transduction and lipid enzymology, and that current readers will benefit from the exposure to top quality research on the new aspects.PLR solely publishes review articles, and submissions are by invitation only. If you have not been invited, but would like to have a review article considered, please send your proposal to the Editorial Office (Mrs. Andy Deelen at A.Deelen@elsevier.com), thereby indicating which editor has the most appropriate expertise to handle the manuscript. Proposals must include a short abstract, proposed table of contents/chapters, a representative figure (if relevant), and a list of key references. Also provide the following information for all co-authors: affiliations, email addresses, and ORCID iDs. The number of co-authors is limited to five and each author is expected to make a substantial contribution to the writing of the manuscript. Your cover letter should include a brief description of the three most significant research papers relevant to the area of the review that are published by the authors’ research group, and an explanation of the current interest and significance to the broad readership of the journal, that is, compelling reasons why the review should be considered. If possible, please supply a timeline for submission of your article. After assessment of the proposal by the Editors, we will let you know whether it is suitable for inclusion in the journal.

From the journal's Aims & Scope

Research area (LetPub): Biochemistry & Molecular Biology

Editorial board by country: 1 in mainland China (about 4%); most named United States 10, Japan 6, France 4, United Kingdom 2, Mainland China 1 (28 members with a country) Editorial board ↗Publisher website · 2026-10-01

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

18.15LetPub · 2026-09-13

Impact factor (publisher)

18.1Publisher website · 2026-10-01

CiteScore 2026-06

34.6LetPub · 2026-09-13

CiteScore (publisher)

34.6Publisher website · 2026-10-01

SJR 2026-06

4.79LetPub · 2026-09-13

SNIP 2026-06

4.74LetPub · 2026-09-13

h-index

132LetPub · 2026-09-13

h-index

222OpenAlex · 2026-10-01

i10-index

988OpenAlex · 2026-10-01

2-year mean citedness

15.94OpenAlex · 2026-10-01

Self-citation rate

0.6%LetPub · 2026-09-13

Share of gold OA articles

50.72%LetPub · 2026-09-13

Volume

Articles per year

22LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

about 14.6 weeksLetPub · 2026-09-13

Average acceptance (community reports)

76%LetPub · 2026-09-13

Submission to first decision

5 daysPublisher website · 2026-10-01

First decision after review

52 daysPublisher website · 2026-10-01

Submission to acceptance

106 daysPublisher website · 2026-10-01

Acceptance to publication

3 daysPublisher website · 2026-10-01

Peer review

Single anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Publisher

Elsevier Ltd

Country or region

ENGLAND

Language

English

Frequency

Quarterly

Founded

1978

ISSN

0163-7827

Electronic ISSN

1873-2194

Official links

• Journal homepage ↗OpenAlex
• Submission system ↗Publisher website
• Special issues ↗Publisher website